Miraculins Inc.

Presenter: Christopher Moreau, President & CEO

Company Information

Company Type: Diagnostics

Development Stage: Public

Company Profile

Miraculins is a medical diagnostic development company focused on non-invasive tests for unmet clinical needs. Miraculins is bridging the gap between commercially available diagnostic tests and research conducted at leading research institutions around the world. The Company's lead program, the development of a test for the devistating disease of maternal health known as preeclampsia, is partnered with Inverness Medical Innovations, one of the worlds leading medical diagnostic companies.

Presenter Bio

Christopher J. Moreau, President & Chief Executive Officer

Christopher Moreau was appointed President and Chief Executive Officer of Miraculins Inc. in February 2007. Previous to his appointment as President & CEO, Mr. Moreau served as Miraculins' Vice-President of Business Development since joining the Company in March 2006. Mr. Moreau has over 20 years of experience in the areas of business development, corporate finance, sales & marketing and operations management. He has held several senior executive roles in sales and marketing within the telecommunications and manufacturing sectors. Prior to joining Miraculins, Mr. Moreau was the President of Advansis Capital Corporation, a privately held Canadian financial services provider.

Contact

Miraculins Inc.
6-1250 Waverley Street
Winnipeg
Manitoba, Canada
R3T 6C6

ph: 204-477-7599
fx: 204-453-1546

www.miraculins.com
cmoreau@miraculins.com